Genomic medicine in clinical practice:national genomic medicine program in Japan

作     者：Teruhiko Yoshida Yasushi Yatabe Ken Kato Genichiro Ishii Akinobu Hamada Hiroyuki Mano Kuniko Sunami Noboru Yamamoto Takashi Kohno Yayoi Ando;Tatsunori Shimoi;Tatsuya Suzuki;Hideki Ueno;Natsuko Okita;Kenichi Nakamura

作者机构：Department of Genetic Medicine and ServicesNational Cancer Center HospitalTokyo 104-0045Japan Department of Diagnostic PathologyNational Cancer Center HospitalTokyo 104-0045Japan Clinical Research Support OffceClinical Research Coordinating SectionBiobank Translational Research Support SectionNational Cancer Center HospitalTokyo 104-0045Japan Department of Pathology and Clinical LaboratoriesNational Cancer Center Hospital EastChiba 277-8577Japan Division of Molecular PharmacologyNational Cancer Center Research InstituteTokyo 104-0045Japan National Cancer Center Research InstituteTokyo 104-0045Japan Department of Laboratory MedicineNational Cancer Center HospitalTokyo 104-0045Japan Department of Experimental TherapeuticsNational Cancer Center HospitalTokyo 104-0045Japan Division of Genome BiologyNational Cancer Center Research InstituteTokyo 104-0045Japan 

出 版 物：《Cancer Biology & Medicine》 (癌症生物学与医学（英文版）)

年 卷 期：2024年第21卷第1期

页      面：4-9页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Cancer cancer death 

摘      要：Cancer statistics in Japan Cancer is the most common cause of death in Japan based on Statistics 2021~*** statistics were first gathered,infectious diseases,such as tuberculosis,and cerebrovascular disease have been the main causes of death in *** surpassed cerebrovascular disease as the main cause of death in 1981,and the number of cancer deaths has *** 38,000 people died of cancer in *** National Cancer Center(NCC)reported that the 5-year survival rate for patients with cancer was improving(62%for males and 66.9%for females)in a population-based cancer registry.